本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TFF Pharmaceuticals

0.0650
0.0000
成交量:- -
成交额:- -
市值:28.88万
市盈率:-0.01
高:0.0650
开:0.0650
低:0.0650
收:0.0650
52周最高:3.23
52周最低:0.0611
股本:444.30万
流通股本:324.24万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.7837
每股收益(LYR):-11.8508
净资产收益率:-220.13%
总资产收益率:-106.45%
市净率:0.09
市盈率(LYR):-0.01

数据加载中...

2025/03/06

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/03/06

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/06

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/06

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/06

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/20

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/20

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/29

重要事件披露

Form 8-K - Current report
2024/06/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]